Navigation Links
Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
Date:2/16/2010

able bowel syndrome, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Stat
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
2. Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
3. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
4. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
5. Lexicon Announces Completion of Public Offering of Common Stock
6. Lexicon Announces Pricing of Common Stock in Public Offering
7. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
8. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
10. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
11. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Dynatronics Corporation (NASDAQ: DYNT ) ... appointed to the Company,s Board of Directors effective March 23, ... November 2014 of board member Joseph Barton .  ... our Board of Directors represents an important step forward for ... president of Dynatronics.  "Rich is a proven leader and is ...
(Date:3/27/2015)... 27, 2015 Biopharmaceutical Industry Leads Manufacturing ... comes out on top as the country,s manufacturing leader ... report  from ndp│analytics. According to the  analysis , the ... over the last decade, accounting for 27 percent of ... A Short Video on Medicare Part D ...
(Date:3/27/2015)... , March 27, 2015   Cypher ... today announced new data showing that, compared to ... technology provided highly equivalent interpretations of whether ... and did so in a fraction of the ... way for more comprehensive genetic analysis in non-invasive ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Week in Review: The Latest from PhRMA 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3
... international study indicates that anti-inflammatory drugs may become a ... (CHD), the leading global cause of death. In investigating ... disease, the researchers used the Cardiochip, a gene analysis ... in the Center for Applied Genomics at The Children,s ...
... Pharma Group today announced that William (Bill) D. Humphries ... Merz Inc., effective March 15, 2012.  In his new ... Dermatology global business unit and will oversee strategic direction ... LLC, Merz Aesthetics, Inc. and Merz Pharma Canada, Ltd.  ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer 2
(Date:3/28/2015)... 2015 The California-based leading wig brand ... customer shopping on UniWigs during the Easter Holidays from ... big promotion on April Fools’ Day. , As the ... around the corner. Easter Festival, with religious origins to ... major holiday after Christmas. The best wig provider, UniWigs, ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes ... first time, key information for understanding and treating this ... posted story on the Surviving Mesothelioma website. ... the British Columbia Cancer Agency, and PhenoPath lab in ... alterations and mutations that can lead to peritoneal ...
(Date:3/28/2015)... 28, 2015 The "Petrick Sustainable ... sustainable health. After 18 years of research and experience ... UFC contenders, Dr. Jon Petrick is excited to be ... some of the immediate benefits of this radical new ... levels of strength of the immune system, faster healing ...
(Date:3/28/2015)... LTW Cyber is an innovation hub for technology ... of addressing the needs of the global market for ... to grow while seeking collaborative opportunities with the other ... in LTW Cyber focus on secure application security, grounded ... and analyzing open source. As the hub matures, ...
Breaking Medicine News(10 mins):Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3
... remarkable operation, a multi-disciplinary team of surgeons at the Ohio ... Hospital and Richard J. Solove Research Institute (OSUCCC James) ... patient, and used the healthy, living bones from his amputated ... remaining right pelvis to support a high-tech prosthetic leg. ...
... is usually viewed as more cost effective, MRI is ... performing a cost utility analysis, utilizing an ultrasound as ... with pre-operative MRI to identify alternative and concurrent diagnoses, ... to research being presented at the 2011 American Roentgen ...
... Reporter , WEDNESDAY, May 4 (HealthDay News) -- In ... inhaled steroids, British researchers found that the oral medications ... oral medications, known as leukotriene-receptor antagonists, "have shown similar ... considered for any patient, not as a last option ...
... the May issue of the journal Health Affairs , ... impact of toxic chemicals and air pollutants in the environment, ... and also those already on the market. Leonardo ... Mount Sinai School of Medicine, analyzed the costs of conditions ...
... Maureen Salamon HealthDay Reporter , WEDNESDAY, May 4 ... a concussion while playing sports should immediately pull players off ... kid -- to avoid a potentially permanent brain injury, according ... conference on youth sports injury prevention held by Safe Kids ...
... KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) has ... to 18 South African scientists and students to help ... Africa. These are the first Collaborative Grants awarded ... collaboration between the University of KwaZulu-Natal (UKZN) and the ...
Cached Medicine News:Health News:Ohio State surgeons rebuild pelvis of cancer patient 2Health News:Ohio State surgeons rebuild pelvis of cancer patient 3Health News:Ultrasound combined with pre-operative MRI is cost effective in evaluating rotator cuff tears 2Health News:Asthma Pills Work as Well as Inhaled Steroids: Study 2Health News:Asthma Pills Work as Well as Inhaled Steroids: Study 3Health News:Estimated costs of environmental disease in children at $76.6 billion per year 2Health News:Estimated costs of environmental disease in children at $76.6 billion per year 3Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 2Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 3Health News:K-RITH awards grants to foster teamwork among South African TB/HIV scientists 2
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Shaft angled 45 degrees. Manufactured in titanium....
Solid 13.5 mm wide by 5 mm deep blades. Edge of blades serrated. Dull finish....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: